I believe pcyc was under $1 many years ago. That is why I say over 12,000%
Watch cldx run, run, run.
Thanks for the input stock and gofor. I hope we get news soon!
Sentiment: Strong Buy
Still has a way to go. glta
You can get 10,000 percent or $250 just for 110 from Roche if you can get two indications and two patent extensions for Avastin.
Then you throw in the rest of the pipeline. CLDX is a much better investment for Roche than Alexion. Even at $250, the benefit/cost ratio as compared to Alexion is multiudes higher.
At $25-30/share, 110 valuation without Roche is incorporated. How many more phase 2 trials do we need to run?
...and VRTX, MDVN and several others as valid examples.